New studies demonstrate that treating cancer based on its molecular vulnerabilities, rather than where it originated, could translate to better outcomes for patients
With a new genome sequence, more diverse data sets, and population-specific projects, scientists are making progress in representing humanity’s real DNA diversity.
CAR T therapies juice the immune system. In cancer, they have cured patients who had little hope for survival. Now scientists are asking "What else can they do?"
NFTs have entered a new stage of their life cycle—and the possibilities are endless for this next generation, aptly called Living NFTs.
Scientists in Ontario used machine learning techniques to find telltale signs of cancer in blood samples that were collected up to seven years prior to conventional diagnosis.